Specific active immunotherapy for melanoma.
D000206:Actuarial Analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D012878:Skin Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*
D001500:BCG Vaccine